Knight Cardiovascular Institute: Achievements and Excellence
Why choose us for heart care?
The OHSU Knight Cardiovascular Institute provides top-quality heart and vascular care. We aim for the best possible outcomes for you and your family.
We constantly monitor your safety and review our processes to learn where we can do better. We proudly partner with global and national organizations that work to improve patient care and outcomes.
Achievements in cardiovascular quality
Cardiac Center of Excellence: In 2020, OHSU was the first hospital in the world named a Cardiac Center of Excellence by DNV, an organization that accredits hospitals. OHSU has maintained this honor since then for all three DNV-certified heart programs: heart failure, ventricular assist device and cardiac ischemia (chest pain).
American Heart Association awards: The association’s Get With The Guidelines quality improvement program has honored OHSU with these designations:
- Gold Plus, the top designation, for excellence in heart failure and heart attack care
- Gold, for resuscitation
Insurance awards: Several national insurance companies have named OHSU a Center of Excellence for complex cardiovascular care.
Our excellence
Transcatheter aortic valve replacement: According to the Society of Thoracic Surgeons and the American College of Cardiology, OHSU does better than the national average on:
- Complication rates, such as bleeding or needing a permanent pacemaker
- Survival rates
Coronary artery bypass and aortic valve replacement surgeries: According to the Society of Thoracic Surgeons, OHSU does better than peer hospitals nationwide on:
- Time in the intensive care unit
- Need for blood transfusion
Heart transplant: According to the Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients, OHSU does better than expected on:
- Survival of patients listed for a heart transplant
- Long-term survival of patients with a heart transplant
Research
OHSU is a national leader in research on sudden cardiac arrest. In 2026, we won a $1.7 million, four-year award from the American Heart Association to study how to improve survival of cardiac arrest. The scientist leading the research, Joshua Lupton, M.D., M.P.H., M.Phil, is himself a cardiac arrest survivor.
Philanthropy
Oregon tech executive Renee James donated $3 million in 2026 to support the Knight Cardiovascular Institute’s status as a world-class center for patient care and scientific excellence.